Financial Highlights
 

For the three months ended

For the years ended

(In millions of canadian dollars, except per share amounts or as otherwise noted)
(unaudited)

March 31
2020

Dec. 31
2019

March 31
2019

Dec. 31
2019

Dec. 31
2018

Revenues

11,024 11,485 17,648 47,802 47,025

Net earnings attributable to common shareholders

329 401 536 1,964 2,245

Net earnings per common share

0.50 0.60 0.75 2.89 3.15

Adjusted net earnings attributable to common shareholders(1)(2)

470 654 474 2,240 1,834

Adjusted net earnings per common share(1)(2)

0.71 0.99 0.66 3.30 2.57

Consolidated assets

457,223 471,372 462,511 471,372 447,055

Shareholders’ equity

21,177 20,815 21,781 20,815 21,580

Book value per common share

27.63 27.08 26.54 27.08 26.26

Common shares outstanding (in millions)

664.1 664.1 714.1 664.1 714.1

(1) Adjusted net earnings attribuable to common shareholders and adjusted net earnings per common share are non-IFRS financial measures. Refer to the “Non-IFRS Financial Measures and Presentation” section of the Corporation’s most recent Management’s Discussion and Analysis for the definition of non-IFRS financial measures and their reconciliation with IFRS financial measures.
(2) Effective the first quarter of 2020, the Corporation introduced an enhanced definition of its non-IFRS earnings measure, Adjusted net earnings. This change is consistent with the introduction of base earnings by Lifeco which was introduced in the first quarter of 2020 to reflect management’s view of the operating performance of Lifeco. Refer to the “Non-IFRS Financial Measures and Presentation” section of the Corporation's most recent Management’s Discussion and Analysis for additional details on this measure. The comparative periods have been restated to reflect the introduction of this enhanced measure.                      

 

As at and for the years ended December 31 [in millions of Canadian dollars, except as otherwise noted]
(unaudited)

2019 2018 2017

2016

2015

Consolidated Balance Sheets

         

Cash and cash equivalents

6,272

5,624 5,321 4,396

4,188

Total assets

471,372

447,055 440,224 418,407

417,630

Shareholders’ equity

20,815

21,580 20,513 19,481

19,473

Consolidated Statements of Earnings

         

Revenues

         

Total net premiums

24,489

35,440 33,880 31,125

24,501

Net investment income

13,247

2,822 7,610 10,203

4,319

Fee income

10,066

8,763 8,497 7,794

7,692

Total revenues

47,802

47,025 49,987 49,122

36,512

Expenses

         

Total paid or credited to policyholders

33,091

32,068 35,643 34,675

22,842

Commissions

3,480

3,512 3,712 3,590

3,133

Operating and administrative expenses

7,237

6,997 7,002 6,380

5,883

Financing charges

435

360 432 412

413

Total expenses 

44,243

42,937 46,789 45,057

32,271

Earnings before investments in jointly controlled corporations and associates, and income taxes

3,559

4,088 3,198 4,065

4,241

Share of earnings (losses) of investments in jointly controlled corporations and associates

211

94 200 (98)

224

Earnings before income taxes

3,770

4,182 3,398 3,967

4,465

Income taxes

601

602 584 581

679

Net earnings

3,169

3,580 2,814 3,386

3,786

Attributable to

         

Non-controlling interests

1,066

1,197 964 1,343

1,337

Perpetual preferred shareholders

139

138 133 124

130

Common shareholders

1,964

2,245 1,717 1,919

2,319

 

3,169

3,580 2,814 3,386

3,786

Per share

         

Net earnings attributable to common shareholders

2.89

3.15 2.41 2.69

3.25

Dividends declared on common shares

1.82

1.73 1.65 1.57

1.49

Book value per common share 

27.08

26.26 24.77 23.69

23.69

Market price (Common shares)

         

High

36.02

34.88 37.00 34.70

38.78

Low

25.45

25.21 31.91 29.02

30.28

Year-end

34.94

25.83 34.54 33.56

31.81

Scroll To Top